Background and Objectives: Faricimab is the first intravitreal injection of vascular endothelial growth factor-A and angiopoietin-2 bispecific monoclonal antibody. Here, we evaluate the functional and anatomical outcomes of faricimab treatment in patients with diabetic macular edema (DME) that was refractory to ranibizumab or aflibercept. Materials and Methods: We performed a retrospective, observational, consecutive-case study of patients who had DME that was refractory to treatment with ranibizumab or aflibercept and were treated with faricimab between July 2022 and January 2023 under a pro re nata regimen. All the participants were followed for ≥4 months after the initiation of faricimab. The primary outcome was a recurrence interval of ≥12 weeks, and the secondary outcomes were the changes in best-corrected visual acuity (BCVA) and central macular thickness (CMT). Results: We analyzed 18 eyes of 18 patients. The mean recurrence interval of previous anti-VEGF injection was 5.8 ± 2.5 weeks, which was significantly extended to 10.8 ± 4.9 weeks (p = 0.0005) by the switch to faricimab. Eight patients (44.4%) achieved a recurrence interval of ≥12 weeks. A history of subtenon injection of triamcinolone acetonide (p = 0.0034) and the presence of disorganization of the retinal inner layers (p = 0.0326) were found to be significantly associated with a recurrence interval of <12 weeks. The mean BCVAs were 0.23 ± 0.28 logMAR and 0.19 ± 0.23 logMAR, and the mean CMTs were 473.8 ± 222.0 µm and 381.3 ± 219.4 µm at baseline and 4 months, respectively, but these changes were not statistically significant. None of the patients experienced serious adverse events. Conclusions: Faricimab may extend the treatment interval for patients with DME that is refractory to ranibizumab or aflibercept. DME previously treated with the subtenon injection of triamcinolone acetonide or associated with disorganization of the retinal inner layers may be less likely to be associated with a longer recurrence interval after switching to faricimab.
Background: Facial recognition systems utilizing deep learning techniques can improve the accuracy of facial recognition technology. However, it remains unclear whether these systems should be available for patient identification in a hospital setting. Methods: We evaluated a facial recognition system using deep learning and the built-in camera of an iPad to identify patients. We tested the system under different conditions to assess its authentication scores (AS) and determine its efficacy. Our evaluation included 100 patients in four postures: sitting, supine, and lateral positions, with and without masks, and under nighttime sleeping conditions. Results: Our results show that the unmasked certification rate of 99.7% was significantly higher than the masked rate of 90.8% (p < 0.0001). In addition, we found that the authentication rate exceeded 99% even during nighttime sleeping. Furthermore, the facial recognition system was safe and acceptable for patient identification within a hospital environment. Even for patients wearing masks, we achieved a 100% success rate for authentication regardless of illumination if they were sitting with their eyes open. Conclusions: This is the first systematical study to evaluate facial recognition among hospitalized patients under different situations. The facial recognition system using deep learning for patient identification shows promising results, proving its safety and acceptability, especially in hospital settings where accurate patient identification is crucial.
Purpose: The purpose of this study was to compare the incidence of ciliochoroidal detachment (CCD) after intrascleral lens fixation using the Yamane technique and other vitrectomy procedures. Methods: This retrospective study evaluated patients who underwent intrascleral lens fixation using the Yamane technique at Hiroshima University Hospital between March 2023 and February 2024 and who could be followed up for at least one month. Patients who underwent vitrectomy for macular disease without air- fluid exchange comprised the control group. The frequency of CCD was compared using anterior segment optical coherence tomography imaging. Results: Forty-five eyes of 45 patients (26 men and 19 women, mean age 70.8 years) were included. There were no significant differences in the population means or proportions between the intrascleral fixation and control groups for age, sex ratio, right-to-left eye ratio, preoperative visual acuity, preoperative intraocular pressure (IOP), ocular axis, and corneal thickness. The population mean of IOP on the day after surgery was significantly lower in the Yamane intrascleral fixation group (8.4 mmHg) than in the control group (11.5 mmHg) (P < 0.05). There was no significant difference in the population proportions of CCD on the day after surgery between the Yamane intrascleral fixation group and the control group. However, the CCD incidence was 20 eyes (80%) for the Yamane intrascleral fixation group and 12 eyes (60%) for the control group, which was higher in the intrascleral fixation group. There was no significant difference in population means of IOP or population proportions of CCD at one week and one month. Conclusions: There was no significant difference in population proportions of CCD on the day after surgery, although the CCD rate for the Yamane intrascleral fixation group was higher, and the population mean of the IOP was significantly lower. The Yamane technique assumedly lowered IOP because of the stress placed on the ciliary body. One week after the procedure, the IOP in the intrascleral fixation group normalized.
Introduction: Compared with sub-Tenon’s anesthesia (STA), trans-Tenon’s capsule retrobulbar anesthesia (TTRBA) provides rapid and complete akinesia. However, excessive anesthetic volume may cause complications such as choroidal detachment (CD). Case Presentation: A 59-year-old man who had previously undergone cataract surgery presented with rapidly progressive visual field constriction in the right eye. The best corrected visual acuity (BCVA) was 20/16; intraocular pressure, 13 mm Hg; and axial length, 29.99 mm. Multiple retinal breaks were detected in the superior and nasal retina, with retinal detachment extending from the superior to the inferior retina. Vitrectomy was performed under local anesthesia. STA (2.5 mL lidocaine) was followed by TTRBA (3.0 mL initially, plus an additional total of 4.5 mL administered in two injections) and 7.5 mg intravenous pentazocine. The cumulative TTRBA volume reached 7.5 mL within 50 min. Immediately after the final injection, an orange choroidal elevation developed across the entire retina, including the macula, without vascular whitening. BCVA recovered to 20/20 at 2 weeks postoperatively, with retinal reattachment. Conclusion: This case suggests that repeated intraconal anesthetic injections totaling >7 mL in a short time may induce macula-involving serous CD via sustained intraorbital pressure elevation. Thus, limiting volume and considering lower volume alternatives may reduce risk.
The PreserFlo MicroShunt is a minimally invasive glaucoma drainage device designed to lower intraocular pressure (IOP) with fewer complications compared with those of traditional filtration surgery. Hypotony and choroidal detachment (CD) are known postoperative risks. However, retinal pigment epithelium (RPE) tears and serous retinal detachment following PreserFlo MicroShunt have not been reported previously. We report a case of retinal detachment with an RPE tear under hypotony following minimally invasive glaucoma surgery using a drainage device that required surgical intervention to elevate the IOP and achieve resolution. A 53-year-old man with a history of ocular hypertension and cataract surgery with intraocular lens suturing developed uncontrolled IOP in his right eye. PreserFlo MicroShunt surgery was performed but resulted in hypotony and subsequent CD. Despite initial management with atropine eye drops and oral steroids, retinal detachment with RPE tears developed. Scleral drainage and pars plana vitrectomy with sulfur hexafluoride (SF6) gas tamponade were performed to elevate IOP and stabilize the retinal condition, leading to the successful resolution of the detachment. Postoperatively, the IOP stabilized within the mid-teens without observing recurrence. This is the first reported case of RPE tears and serous retinal detachment following Preserflo MicroShunt surgery. These findings highlight that a rapid and significant reduction in IOP, even without reaching absolute hypotony, might disrupt choroidal circulation and RPE integrity, particularly in eyes with predisposing factors, such as atopic dermatitis and long-term steroid use. Early recognition of CD and timely intervention to elevate IOP are crucial for preventing vision-threatening complications.
Capsular changes after congenital cataract surgery may compromise the visual axis in infants and may necessitate secondary surgical intervention. In such s